About CreoMed

About Us

A Letter from the founder...

We at CreoMed Inc. are dedicated to providing our clients with safe and effective novel products of the highest quality, created from a sound scientific foundation: “the science behind nature”. Our innovative family of products responds to the public’s increasing demand for superior natural health remedies.
Our core team of professionals have over 100 years of combined experience in the health care industry. We have extensive experience in drug and natural compound discovery from pre-clinical and clinical testing through marketing; “we turn scientific concepts into products”. CreoMed’s Medial advisory board members assume a hands on approach by actively reviewing the scientific integrity of each product. Our Medical advisory board is composed of internationally recognized experts in their respective scientific fields. Our manufactures adhere to the highest global regulatory standards, all being GMP FDA Certified Facilities. CreoMed holds the propriety patent for a unique process that enhances the physiochemical and electrostatic properties of our exclusive compounds by increasing their activity. A combination of the elements above provides a unique competitive advantage for CreoMed’s distributors.

In an industry beset by me-toos and copycats, CreoMed’s products are truly unique with novel mechanisms of action that have shown to be safe and effective while supporting a cacophony of healthy maintenance functions. CreoMed maintains a large proprietary pipeline of novel superior natural supplements, cosmetics, essential oils, apparel and health revitalizing products.

As founder and CEO, my personal and professional commitment is to ensure that the highest of standards, ethics and services are adhered to not only in the development and creation of CreoMed products, but to our private label clients, distributors and partners. When you think CreoMed – think competitive advantage “the science behind nature”!

Welcome to the next generation of natural products!

Joseph V. Pergolizzi, Jr. MD
CEO and Founding Partner

History & Goals -

CreoMed seeks to lead the nutraceutical and cosmeceutical industry by focusing on premier nutraceutical supplements, cosmeceutical and pharmaceutical products. The company is positioning itself to compete globally by establishing proper dosing and optimal treatment monitoring for all of its products based on sound science and clinical testing; “quantifying the qualitative”. Through the development of a cost efficient system of distribution and the building of a strong brand, the company anticipates significant acceptance of its products in the market.

CreoMed is focused on four primary lines of business: nutraceuticals, consumer products, technology licensing and apparel. CreoMed is the owner of the proprietary patent micronanostatic-activated (MNSA) products and manufacturing technology. CreoMed’s product line of dietary supplements is well positioned to meet the growing demand for nutraceuticals and is designed to promote general wellness, slow aging, optimize organ functions and boost healing and immunity.

CreoMed is committed to developing effective products, proper dosing and optimal treatment monitoring based on sound science and clinical testing. It foresees building out its product line through cost effective research and judicious licensing. Product extensions are targeted for areas for which consumers are exhibiting significant interest including pain management, weight loss, ophthalmology, gastrointestinal disease and general wellness. Business development opportunities pertaining to the development of functional foods and/or food additives are also planned.

CreoMed offers four (4) unique lines:

a.) Mineral-based antioxidant supplements and cosmetics manufactured using MNSA technology

b.) MNSA thermogenic-synbiotic-konjac-based weight loss product line

c.) “Liquid vitamin and essential oils” athletic line

d.) Symbiotic oral and cosmetic line

CreoMed believes that its products promote general wellness, assist with slower aging and improve organ function, healing and immunity primarily through the unique properties of the products offered to the market.

CreoMed is developing a testing and monitoring program that will allow practitioners to monitor treatment efficacy. Through a certification process, the firm intends to strengthen its position in the channel and encourage sales by helping practitioners differentiate themselves and create alternative revenue opportunities for their practices.

The management team and advisory board consists of business leaders from healthcare, more generally, and the pharmaceutical industry in particular. Management has especially strong track record in clinical research, pharmaceutical marketing and sales, business development and regulatory relations.